Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids

3Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Cellular plasticity is enhanced by dedifferentiation processes such as epithelial-mesenchymal transition (EMT). The dynamic and transient nature of EMT-like processes challenges the investigation of cell plasticity in patient-derived breast cancer models. Here, we utilized patient-derived organoids (PDOs) as a model to study the susceptibility of primary breast cancer cells to EMT. Upon induction with TGF-β, PDOs exhibited EMT-like features, including morphological changes, E-cadherin downregulation and cytoskeletal reorganization, leading to an invasive phenotype. Image analysis and the integration of deep learning algorithms enabled the implantation of microscopy-based quantifications demonstrating repetitive results between organoid lines from different breast cancer patients. Interestingly, epithelial plasticity was also expressed in terms of alterations in luminal and myoepithelial distribution upon TGF-β induction. The effective modeling of dynamic processes such as EMT in organoids and their characteristic spatial diversity highlight their potential to advance research on cancer cell plasticity in cancer patients.

Cite

CITATION STYLE

APA

Bar-Hai, N., Ben-Yishay, R., Arbili-Yarhi, S., Herman, N., Avidan-Noy, V., Menes, T., … Ishay-Ronen, D. (2024). Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1470379

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free